Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

[Cystic fibrosis, the transition to adult centres].

Vion-Genovese V, Cheick M, Rombdalle-Balle S, Llerena C.

Rev Infirm. 2020 Jan;69(257):23-24. doi: 10.1016/j.revinf.2019.12.010. Epub 2019 Dec 26. French.

PMID:
32146959
2.

Extensively resistant tuberculosis, Colombia, 2006-2016

Zabaleta A, Llerena C.

Biomedica. 2019 Dec 1;39(4):707-714. doi: 10.7705/biomedica.4842. English, Spanish.

3.

Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data.

Rouzé H, Viprey M, Allemann S, Dima AL, Caillet P, Denis A, Poupon-Bourdy S, Camara B, Llerena C, Reix P, Durieu I, Reynaud Q, Touzet S.

Patient Prefer Adherence. 2019 Sep 4;13:1497-1510. doi: 10.2147/PPA.S211769. eCollection 2019.

4.

The Importance of investigating Mycobacterium bovis in clinical samples of human origin

Martínez JC, Llerena C, Valbuena YA.

Biomedica. 2019 May 1;39(s1):117-124. doi: 10.7705/biomedica.v39i2.4358. English, Spanish.

5.

Characterization of clinical isolates of Mycobacterium tuberculosis from indigenous peoples of Colombia

Puerto D, Erazo L, Zabaleta A, Murcia MI, Llerena C, Puerto G.

Biomedica. 2019 Aug 1;39(Supl. 2):78-92. doi: 10.7705/biomedica.v39i3.4318. English, Spanish.

6.

Resistant tuberculosis in children under 15 years of age, Colombia 2010-2015

Zabaleta AP, Llerena C, Valbuena A.

Biomedica. 2019 Jun 15;39(2):330-338. doi: 10.7705/biomedica.v39i3.4258. English, Spanish.

7.

[Quality criteria for the transition to adult care in French CF centers - results from the SAFETIM APP study?]

Vion Genovese V, Perceval M, Buscarlet-Jardine L, Pinsault N, Gauchet A, David V, Durieu I, Llerena C.

Rev Mal Respir. 2019 May;36(5):565-577. doi: 10.1016/j.rmr.2019.01.008. Epub 2019 Jun 14. French.

PMID:
31208888
8.

Mycobacterioses identified in the National Reference Laboratory of Colombia from 2012 to 2016

Llerena C, Valbuena A, Zabaleta AP.

Biomedica. 2018 Aug 1;38(0):87-94. doi: 10.7705/biomedica.v38i0.4143.

9.

High-resolution hydrometeorological data from a network of headwater catchments in the tropical Andes.

Ochoa-Tocachi BF, Buytaert W, Antiporta J, Acosta L, Bardales JD, Célleri R, Crespo P, Fuentes P, Gil-Ríos J, Guallpa M, Llerena C, Olaya D, Pardo P, Rojas G, Villacís M, Villazón M, Viñas P, De Bièvre B.

Sci Data. 2018 Jul 3;5:180080. doi: 10.1038/sdata.2018.80.

10.

Glucose trajectories in cystic fibrosis and their association with pulmonary function.

Reynaud Q, Rabilloud M, Roche S, Poupon-Bourdy S, Iwaz J, Nove-Josserand R, Blond E, Laville M, Llerena C, Quetant S, Reix P, Touzet S, Durieu I.

J Cyst Fibros. 2018 May;17(3):400-406. doi: 10.1016/j.jcf.2017.09.010. Epub 2017 Oct 14.

PMID:
29037538
11.

Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study.

Coron N, Pihet M, Fréalle E, Lemeille Y, Pinel C, Pelloux H, Gargala G, Favennec L, Accoceberry I, Durand-Joly I, Dalle F, Huet F, Fanton A, Boldron A, Loeuille GA, Domblides P, Coltey B, Pin I, Llerena C, Troussier F, Person C, Marguet C, Wizla N, Thumerelle C, Turck D, Bui S, Fayon M, Duhamel A, Prévotat A, Wallaert B, Leroy S, Bouchara JP, Delhaes L.

Mycopathologia. 2018 Feb;183(1):101-117. doi: 10.1007/s11046-017-0173-1. Epub 2017 Jul 26.

PMID:
28748285
12.

[Prevalence of Mycobacterium tuberculosis resistance to quinolones and injectables in Colombia, 2012-2013].

Llerena C, Zabaleta A, Valbuena A, Murcia M.

Biomedica. 2017 Jan 24;37(1):96-103. doi: 10.7705/biomedica.v37i2.3204. Spanish.

13.

[Characterization of clinical isolates of Mycobacterium tuberculosis from HIV positive individuals in Colombia, 2012].

Castro C, Ricardo A, Zabaleta A, Llerena C, Puerto G.

Biomedica. 2017 Jan 24;37(1):86-95. doi: 10.7705/biomedica.v37i1.3112. Spanish.

14.
15.

An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth.

Atapattu L, Saha N, Chheang C, Eissman MF, Xu K, Vail ME, Hii L, Llerena C, Liu Z, Horvay K, Abud HE, Kusebauch U, Moritz RL, Ding BS, Cao Z, Rafii S, Ernst M, Scott AM, Nikolov DB, Lackmann M, Janes PW.

J Exp Med. 2016 Aug 22;213(9):1741-57. doi: 10.1084/jem.20151095. Epub 2016 Aug 8.

16.

PTP-PEST controls EphA3 activation and ephrin-induced cytoskeletal remodelling.

Mansour M, Nievergall E, Gegenbauer K, Llerena C, Atapattu L, Hallé M, Tremblay ML, Janes PW, Lackmann M.

J Cell Sci. 2016 Jan 15;129(2):277-89. doi: 10.1242/jcs.174490. Epub 2015 Dec 7.

17.

[Tuberculosis and drug-resistance tuberculosis in prisoners. Colombia, 2010-2012].

Gómez IT, Llerena CR, Zabaleta AP.

Rev Salud Publica (Bogota). 2015 Jan-Feb;17(1):97-105. Spanish.

18.

[Evaluation of the BD MGITTM technique for identifying the Mycobacterium tuberculosis complex].

Gómez IT, Llerena CR, Zabaleta AP.

Rev Salud Publica (Bogota). 2014 Sep-Oct;16(5):765-71. Spanish.

19.

Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth.

To C, Farnsworth RH, Vail ME, Chheang C, Gargett CE, Murone C, Llerena C, Major AT, Scott AM, Janes PW, Lackmann M.

PLoS One. 2014 Nov 24;9(11):e112106. doi: 10.1371/journal.pone.0112106. eCollection 2014.

20.

Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.

Vail ME, Murone C, Tan A, Hii L, Abebe D, Janes PW, Lee FT, Baer M, Palath V, Bebbington C, Yarranton G, Llerena C, Garic S, Abramson D, Cartwright G, Scott AM, Lackmann M.

Cancer Res. 2014 Aug 15;74(16):4470-81. doi: 10.1158/0008-5472.CAN-14-0218.

21.

[National French guidelines for management of infants with cystic fibrosis].

Sermet-Gaudelus I, Couderc L, Vrielynck S, Brouard J, Weiss L, Wizla N, Llerena C, Lebourgeois M, Bailly C, Dirou A, Renouil M, Dalphin ML, Rault G, Munck A, Roussey M; Groupe de travail dépistage de la Fédération des centres de ressources et de compétences de la mucoviscidose; Groupe de travail dépistage de la Fédération des centres de ressources et de compétences de la mucoviscidose.

Arch Pediatr. 2014 Jun;21(6):654-62. doi: 10.1016/j.arcped.2014.03.014. Epub 2014 May 10. French.

PMID:
24815598
22.

Wearable biomedical measurement systems for assessment of mental stress of combatants in real time.

Seoane F, Mohino-Herranz I, Ferreira J, Alvarez L, Buendia R, Ayllón D, Llerena C, Gil-Pita R.

Sensors (Basel). 2014 Apr 22;14(4):7120-41. doi: 10.3390/s140407120.

23.

Sensorized garments and textrode-enabled measurement instrumentation for ambulatory assessment of the autonomic nervous system response in the ATREC project.

Seoane F, Ferreira J, Alvarez L, Buendia R, Ayllón D, Llerena C, Gil-Pita R.

Sensors (Basel). 2013 Jul 12;13(7):8997-9015. doi: 10.3390/s130708997.

24.

Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function.

Atapattu L, Saha N, Llerena C, Vail ME, Scott AM, Nikolov DB, Lackmann M, Janes PW.

J Cell Sci. 2012 Dec 15;125(Pt 24):6084-93. doi: 10.1242/jcs.112631. Epub 2012 Oct 29.

25.

[Drug-resistant Mycobacterium tuberculosis in children under 15 years].

Llerena C, Fadul SE, Garzón MC, Mejía G, Orjuela DL, García LM, Alvarez HB, Ruiz FJ.

Biomedica. 2010 Jul-Sep;30(3):362-70. Spanish.

PMID:
21713338
26.

Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients.

Fricker-Hidalgo H, Coltey B, Llerena C, Renversez JC, Grillot R, Pin I, Pelloux H, Pinel C.

Clin Vaccine Immunol. 2010 Sep;17(9):1330-6. doi: 10.1128/CVI.00200-10. Epub 2010 Jul 14.

27.

[Screening and management of glucose metabolism disorders in cystic fibrosis patients. Practices survey in 4 French reference centers].

Haesebaert J, Bourdy S, Perceval M, Chabloz C, Nove-Josserand R, Reix P, Llerena C, Wion N, Touzet S.

Arch Pediatr. 2009 Nov;16(11):1435-42. doi: 10.1016/j.arcped.2009.07.025. Epub 2009 Oct 6. French.

PMID:
19811898
28.

[Influenza vaccination coverage in asthmatic children in France in 2006-2007].

Rancé F, Chave C, de Blic J, Deschildre A, Donato L, Dubus JC, Fayon M, Labbe A, Le Bourgeois M, Llerena C, Le Manach G, Pin I, Santos C, Thumerelle C, Aubert M, Weil-Olivier C.

Arch Pediatr. 2008 Nov;15(11):1724-8. French.

PMID:
19090033
29.

[Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs].

Garzón MC, Angée DY, Llerena C, Orjuela DL, Victoria JE.

Biomedica. 2008 Sep;28(3):319-26. Spanish.

PMID:
19034356
30.

Low influenza vaccination coverage in asthmatic children in France in 2006-7.

Rance F, Chave C, De Blic J, Deschildre A, Donato L, Dubus J, Fayon M, Labbe A, Le Bourgeois M, Llerena C, Le Manach G, Pin I, Santos C, Thumerelle C, Aubert M, Weil-Olivier C.

Euro Surveill. 2008 Oct 23;13(43). pii: 19016.

31.

[Recurrent pneumonia revealing a bronchial carcinoid tumor: report of two cases].

Hullo E, Llerena C, Durand C, Piolat C, Plantaz D, Pin I.

Arch Pediatr. 2007 Aug;14(8):1036-40. Epub 2007 Jun 12. French.

PMID:
17566721
32.

Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.

Rios FG, Luna CM, Maskin B, Saenz Valiente A, Lloria M, Gando S, Sosa C, Baquero S, Llerena C, Petrati C, Apezteguia C.

Eur Respir J. 2007 Aug;30(2):307-13. Epub 2007 May 15.

33.

[Lepto-dipstick: results of its application to the fast diagnosis of human leptospirosis].

Rodríguez I, Fernández C, Llerena C, Victoria B, Rodríguez JE, Obregón AM.

Rev Cubana Med Trop. 2002 Jan-Apr;54(1):44-7. Spanish.

PMID:
15846940
34.

[Environment and asthma in children: controversies].

Pin I, Pilenko C, Chatain P, Llerena C, Bost M.

Arch Pediatr. 2004 Jun;11 Suppl 2:93s-97s. Review. French.

PMID:
15301804
35.

Lutein and zeaxanthin in the eyes, serum and diet of human subjects.

Bone RA, Landrum JT, Dixon Z, Chen Y, Llerena CM.

Exp Eye Res. 2000 Sep;71(3):239-45.

PMID:
10973733
36.

Measurements of respiratory system resistance by the interrupter technique in healthy and asthmatic children.

Oswald-Mammosser M, Llerena C, Speich JP, Donata L, Lonsdorfer.

Pediatr Pulmonol. 1997 Aug;24(2):78-85.

PMID:
9292898
37.

[Model for the analysis of child survival].

Arroyo P, Langer A, Avila H, Llerena C.

Salud Publica Mex. 1988 May-Jun;30(3):463-9. Spanish. No abstract available.

PMID:
3187741
38.

[Models of primary health attention].

Llerena C, Arroyo P.

Salud Publica Mex. 1985 Nov-Dec;27(6):540-6. Spanish. No abstract available.

PMID:
4089672
39.

[Waiting time for medical care].

Llerena CM, Alvarez G.

Salud Publica Mex. 1984 Jan-Feb;26(1):50-9. Spanish. No abstract available.

PMID:
6719271
40.

Subcutaneous fat accumulation during pregnancy in a malnourished population.

Arroyo P, García D, Llerena C, Quiroz SE.

Br J Nutr. 1978 Nov;40(3):485-9.

PMID:
718830
41.

Practical application of computer-assisted decision-making in an antenatal clinic--a feasibility study.

Anderson G, Llerena C, Davidson D, Taylor TR.

Methods Inf Med. 1976 Oct;15(4):224-9. No abstract available.

PMID:
792631

Supplemental Content

Loading ...
Support Center